Geoffrey M. Nichol
2012
In 2012, Geoffrey M. Nichol earned a total compensation of $1.3M as Executive Vice President, Research and Development at Sangamo Biosciences, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $178,200 |
|---|---|
| Option Awards | $416,460 |
| Salary | $440,000 |
| Stock Awards | $297,550 |
| Total | $1,332,210 |
Nichol received $440K in salary, accounting for 33% of the total pay in 2012.
Nichol also received $178.2K in non-equity incentive plan, $416.5K in option awards and $297.6K in stock awards.
Rankings
In 2012, Geoffrey M. Nichol's compensation ranked 5,006th out of 11,487 executives tracked by ExecPay. In other words, Nichol earned more than 56.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,006 out of 11,487 | 56th |
Division Manufacturing | 1,752 out of 4,253 | 59th |
Major group Chemicals And Allied Products | 417 out of 1,203 | 65th |
Industry group Drugs | 269 out of 925 | 71st |
Industry Biological Products, Except Diagnostic Substances | 45 out of 165 | 73rd |
Source: SEC filing on March 11, 2014.
Nichol's colleagues
We found four more compensation records of executives who worked with Geoffrey M. Nichol at Sangamo Biosciences in 2012.